78 related articles for article (PubMed ID: 25796600)
1. Association of SPP1 promoter variants with hip osteoarthritis susceptibility in Chinese population.
Lv C; Li Y; Xu J; Cao H; Li X; Ma B; Ning P; Wang Y; Wang M; Zhu S; Ge Y; Huang S; Jin Y
Gene; 2015 Jun; 564(1):9-13. PubMed ID: 25796600
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin promoter polymorphisms and risk of urolithiasis: a candidate gene association and meta-analysis study.
Amar A; Afzal A; Hameed A; Ahmad M; Khan AR; Najma H; Abid A; Khaliq S
BMC Med Genet; 2020 Aug; 21(1):172. PubMed ID: 32842990
[TBL] [Abstract][Full Text] [Related]
3. The (-765 G→C) promoter variant of the COX-2/PTGS2 gene is associated with a lower risk for end-stage hip and knee osteoarthritis.
Schneider EM; Du W; Fiedler J; Högel J; Günther KP; Brenner H; Brenner RE
Ann Rheum Dis; 2011 Aug; 70(8):1458-60. PubMed ID: 20378913
[TBL] [Abstract][Full Text] [Related]
4. A functional single nucleotide polymorphism in the core promoter region of CALM1 is associated with hip osteoarthritis in Japanese.
Mototani H; Mabuchi A; Saito S; Fujioka M; Iida A; Takatori Y; Kotani A; Kubo T; Nakamura K; Sekine A; Murakami Y; Tsunoda T; Notoya K; Nakamura Y; Ikegawa S
Hum Mol Genet; 2005 Apr; 14(8):1009-17. PubMed ID: 15746150
[TBL] [Abstract][Full Text] [Related]
5. SPP1 polymorphisms associated with HBV clearance and HCC occurrence.
Shin HD; Park BL; Cheong HS; Yoon JH; Kim YJ; Lee HS
Int J Epidemiol; 2007 Oct; 36(5):1001-8. PubMed ID: 17496055
[TBL] [Abstract][Full Text] [Related]
6. The CALM1 core promoter polymorphism is not associated with hip osteoarthritis in a United Kingdom Caucasian population.
Loughlin J; Sinsheimer JS; Carr A; Chapman K
Osteoarthritis Cartilage; 2006 Mar; 14(3):295-8. PubMed ID: 16359877
[TBL] [Abstract][Full Text] [Related]
7. Differential gene expression of bone anabolic factors and trabecular bone architectural changes in the proximal femoral shaft of primary hip osteoarthritis patients.
Truong LH; Kuliwaba JS; Tsangari H; Fazzalari NL
Arthritis Res Ther; 2006; 8(6):R188. PubMed ID: 17187661
[TBL] [Abstract][Full Text] [Related]
8. The impact of osteopontin promoter polymorphisms on the risk of calcium urolithiasis.
Liu CC; Huang SP; Tsai LY; Wu WJ; Juo SH; Chou YH; Huang CH; Wu MT
Clin Chim Acta; 2010 May; 411(9-10):739-43. PubMed ID: 20144595
[TBL] [Abstract][Full Text] [Related]
9. Additional Evidence Supports Association of Common Variants in COL11A1 with Increased Risk of Hip Osteoarthritis Susceptibility.
Wang J; Zhang C; Wu SG; Shang C; Huang L; Zhang T; Zhang W; Zhang Y; Zhang L
Genet Test Mol Biomarkers; 2017 Feb; 21(2):86-91. PubMed ID: 27936936
[TBL] [Abstract][Full Text] [Related]
10. SPP1 promoter polymorphisms and glioma risk in a Chinese Han population.
Chen J; Wu Q; Lu Y; Xu T; Huang Y; Ribas J; Ni X; Hu G; Huang F; Zhou L; Lu D
J Hum Genet; 2010 Jul; 55(7):456-61. PubMed ID: 20505679
[TBL] [Abstract][Full Text] [Related]
11. Increased type II deiodinase protein in OA-affected cartilage and allelic imbalance of OA risk polymorphism rs225014 at DIO2 in human OA joint tissues.
Bos SD; Bovée JV; Duijnisveld BJ; Raine EV; van Dalen WJ; Ramos YF; van der Breggen R; Nelissen RG; Slagboom PE; Loughlin J; Meulenbelt I
Ann Rheum Dis; 2012 Jul; 71(7):1254-8. PubMed ID: 22492780
[TBL] [Abstract][Full Text] [Related]
12. Functional variants within the secreted frizzled-related protein 3 gene are associated with hip osteoarthritis in females.
Loughlin J; Dowling B; Chapman K; Marcelline L; Mustafa Z; Southam L; Ferreira A; Ciesielski C; Carson DA; Corr M
Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9757-62. PubMed ID: 15210948
[TBL] [Abstract][Full Text] [Related]
13. Association between polymorphisms in osteopontin gene (SPP1) and first episode calcium oxalate urolithiasis.
Safarinejad MR; Shafiei N; Safarinejad S
Urolithiasis; 2013 Aug; 41(4):303-13. PubMed ID: 23784265
[TBL] [Abstract][Full Text] [Related]
14. A Case-Control Study of the Association Between the SPP1 Gene SNPs and the Susceptibility to Breast Cancer in Guangxi, China.
Liang L; Lu G; Pan G; Deng Y; Liang J; Liang L; Liu J; Tang Y; Wei G
Front Oncol; 2019; 9():1415. PubMed ID: 31921672
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 gene polymorphism and risk of osteoarthritis of the hip: a case-control study.
Pola E; Papaleo P; Pola R; Gaetani E; Tamburelli FC; Aulisa L; Logroscino CA
Osteoarthritis Cartilage; 2005 Nov; 13(11):1025-8. PubMed ID: 16198603
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and inheritance of hip osteoarthritis in Iceland.
Ingvarsson T
Acta Orthop Scand Suppl; 2000 Dec; 298():1-46. PubMed ID: 11338422
[TBL] [Abstract][Full Text] [Related]
17. OPN gene polymorphisms, rs17524488 GG/G, rs11730582 T/C, and rs9138 C/A, and cancer risk in a Chinese population.
Mi Y; Ren K; Dai F; Zhu L; Feng N
Sci Rep; 2015 Sep; 5():14164. PubMed ID: 26369832
[TBL] [Abstract][Full Text] [Related]
18. Genetic association analysis of LRCH1 as an osteoarthritis susceptibility locus.
Snelling S; Sinsheimer JS; Carr A; Loughlin J
Rheumatology (Oxford); 2007 Feb; 46(2):250-2. PubMed ID: 16891653
[TBL] [Abstract][Full Text] [Related]
19. SPP1 gene polymorphisms associated with nephrolithiasis in Turkish pediatric patients.
Tekin G; Ertan P; Horasan G; Berdeli A
Urol J; 2012; 9(4):640-7. PubMed ID: 23235966
[TBL] [Abstract][Full Text] [Related]
20. Association of interleukin-6 and transforming growth factor-β1 gene polymorphisms with developmental hip dysplasia and severe adult hip osteoarthritis: a preliminary study.
Kolundžić R; Trkulja V; Mikolaučić M; Kolundžić MJ; Pavelić SK; Pavelić K
Cytokine; 2011 May; 54(2):125-8. PubMed ID: 21353594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
